Physical Pharmacy and Formulation
A section of Pharmaceutics (ISSN 1999-4923).
Section Information
This section is intended to rapidly publish all aspects of current issues in physicochemical characterization of drug substances including proteins, and their formulation design and products development. An example of specific topics includes but not limited to:
Physical Pharmacy
- Solubility
- Solubilization
- Dissolution
- Polymorphism
- Permeability
- Stability and stabilization
- New materials for controlling drug characteristics
- Analytical techniques
Formulation
- Novel excipients
- Formulation science
- Drug delivery systems
- Controlled release
- Drug targeting
- Bioavailability
- Quality-by-design
- Regulatory science
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Polymorphism (Deadline: 30 September 2023)
- The Latest Development of Multifunctional Nanopharmaceutical Formulations and Its Application (Deadline: 30 September 2023)
- Essential Oils in Pharmaceutical Products (Volume II) (Deadline: 30 September 2023)
- Machine Learning for Dosage Forms Developments (Deadline: 30 September 2023)
- Advances in Natural Products for Cutaneous Application (Deadline: 15 October 2023)
- Pharmacy Compounding of Personalized Preparation for Specific Patients: Challenges and Advantages (Deadline: 20 October 2023)
- Oxidative Stress and Inflammation: Novel Drug Formulation and Delivery Systems (Deadline: 20 October 2023)
- Advances in Pickering-Emulsion-Based Drug Delivery Systems (Deadline: 30 October 2023)
- Advances in Amorphous Drug Formulations, Volume II (Deadline: 31 October 2023)
- Pharmaceutical Formulations with Antimicrobial Properties, 2nd Edition (Deadline: 31 October 2023)
- Formulation and Delivery of Traditional Medicines and Natural Products (Deadline: 31 October 2023)
- Semisolid Dosage (Volume III) (Deadline: 31 October 2023)
- Polymorphism and Pseudopolymorphism of Pharmaceutical Substances (Deadline: 31 October 2023)
- Stability and Formulation of Drug Substances and Pharmaceutical Products (Deadline: 31 October 2023)
- Hybrid Materials and Their Applications in the Pharmaceutical or Medical Field (Deadline: 1 November 2023)
- Biopolymers for Biomedical and Pharmaceutical Applications (Deadline: 30 November 2023)
- Essential Oil in Pharmaceutical Products for the Management of Chronic Diseases (Deadline: 30 November 2023)
- New Perspectives for the Administration of Cannabis for Medical Use: From Traditional to Advanced Formulations. What Next? (Deadline: 30 November 2023)
- Recent Advances in Drugs and Prodrugs Design in the Field of Infectious Diseases (Deadline: 30 November 2023)
- Drug Polymorphism and Dosage Form Design (Volume II) (Deadline: 30 November 2023)
- Multicomponent Solid Forms as Modifying Agents for Drugs with Solubility Problems (Deadline: 30 November 2023)
- HIV/AIDS Prevention Formulation Design and Optimization and Its Pharmacokinetic-Pharmacodynamic Evaluation (Deadline: 30 November 2023)
- Novel Dry Powder Formulation and Delivery Systems (Deadline: 15 December 2023)
- Orally Disintegrating Dosage Forms Based on Cyclodextrins and Hydrophilic Polymers (Deadline: 20 December 2023)
- Pharmaceutical Polymorphs and Cocrystals and Their In Vitro and In Vivo Evaluation (Deadline: 20 December 2023)
- New Trends in the Controlled Release Systems of Medicinal Substances Used in the Treatment of Diseases of the Central Nervous System (Deadline: 20 December 2023)
- Advanced Pediatric Drug Formulation Strategies (Deadline: 20 December 2023)
- Research on the Prediction and Optimization of the Solubility and Permeability of Biopharmaceuticals (Deadline: 20 December 2023)
- Recent Advances in Pharmaceutical Dosage Forms (Deadline: 31 December 2023)
- Cell and Tissue-Based Formulations: from Design to Biomedical Applications (Deadline: 31 December 2023)
- Pharmaceutical Dosage Forms: Drug Release, Solubility and Stability Evaluation (Deadline: 31 December 2023)
- Modeling, Simulation and Data Analysis of Pharmaceutical Manufacturing Processes (Deadline: 31 December 2023)
- Controlled Crystallization of Active Pharmaceutical Ingredients, 2nd Edition (Deadline: 31 December 2023)
- Advanced Pharmaceutical Science and Technology in Germany (Deadline: 31 December 2023)
- Formulation of Poorly Water-Soluble Drugs (Deadline: 31 December 2023)
- Spray Drying and Encapsulation of Pharmaceuticals and Phytopharmaceuticals (Deadline: 31 December 2023)
- Stability of Medicines and Novel Approaches for Predicting Drug Stability (Deadline: 10 January 2024)
- Pharmaceutical Solid Forms: From Crystal Structure to Formulation (Deadline: 20 January 2024)
- Advanced Spray Drying Technology in Pharmaceutical Formulations: Novel Applications Using Polymeric and Lipidic Excipients (Deadline: 20 January 2024)
- Antimicrobial Agents Based on Nanomaterials (Deadline: 20 January 2024)
- Advances in Pharmaceutical Nanocrystals (Deadline: 20 January 2024)
- Innovative Formulations of Poorly Soluble Drugs (Deadline: 20 January 2024)
- Recent Advances in Oral Solid Dosages—2nd Edition (Deadline: 31 January 2024)
- Nanoparticle-Mediated Diagnostics and Drug Delivery Therapy (Deadline: 24 February 2024)
- Biofunctional Pharmaceutical Additives for Targeted, Improved Bioavailability and Safety of Medicine (Deadline: 31 March 2024)
- Biomedical Applications of Topical Formulations for Skin and Mucosal Disorders (Deadline: 15 April 2024)
Topical Collection
Following topical collection within this section is currently open for submissions:
